◆ 會議時間：2024年9月11-15日
◆ 會議地點：美國 芝加哥
◆ 會議簡介：
2024年國際乙型肝炎病毒(HBV)會議將于2024年9月11-15日在美國芝加哥舉行。
國際乙型肝炎病毒（HBV）分子生物學會議是由Jesse Summers博士和Harold Varmus博士于1985年在紐約發(fā)起舉辦，是國際上專注于乙肝病毒（HBV）和丁型肝炎病毒（HDV）的權威科學會議，目的是匯集研究乙肝和丁肝病毒、相關動物模型病毒及乙型肝炎誘導肝細胞癌方面的國際科學家，為初級和高級科學家宣提供廣泛的機會，共同討論關于這些病毒病原體和相關疾病的最新概念和技術進展。大會主題包括生物化學、分子生物學、傳統(tǒng)病毒學、免疫學、發(fā)病機理和致癌作用，以及針對這兩種病毒的抗病毒治療的最新進展。未經許可禁止復制摘錄轉載本站任何內容-國際醫(yī)學會議網（lingyuint.com）.
2024 International HBV Meeting
時間/Date:
September 11-15, 2024
地點/Venue:
Chicago, USA
摘要征文投稿：
Abstract Submission
General Abstracts
- All abstracts must be submitted by?3 p.m. EDT on June 20, 2024, to be considered for presentation at the HBV Meeting. Presentation notifications will be sent in timeline?to be announced.?
- Click on the button below to access the Abstract Submission Portal; going live in February 2024.
點此提交摘要>>>Submit Abstract>>>
Abstracts will be submitted to the following session topics.
- Molecular Virology
- Immunology/Pathogenesis
- Therapy
Abstracts that are selected for presentations will be allocated to a session by the meeting organizers.?
- The presenting author MUST be registered for the meeting in order for an abstract to be included in the program book.
- Oral and Poster Presentation Guidelines will be shared as the meeting approaches.?
Details about abstract submissions:
- Titles should use "sentence caps" style, i.e., only capitalize the first word in the title and use lowercase for remainder of title (except if the scientific word requires caps such as 'HBV' or 'DNA,' etc.).?
- Abstracts must be 300 words or less.
- We encourage attendees to submit abstracts that have not yet been published. Those that have been published elsewhere and do not have?significant new information will get low priority to be selected for an oral presentation.
Important dates to note:?
- June 20, 2024, will be the last day to submit abstracts and travel grants.
- Late July is when presentation and travel grant recipients will be notified.?
- Late July will be the presentation and travel grant acceptance deadline.?
Important Reminder:
- All travel grant requests must be submitted by?3 p.m. EDT on June 20, 2024.
注冊費：
Early bird registration will end 7/20/24.
Late registration will close 8/18/24.
Final payment due on 8/23/24.
An?Early Career Scientist?is a scientist/researcher with 5-6 years post-doctorate experience or less, who does not work independently and is not the "Principal Investigator" on grants.
Regular Members?are scientists and researchers working for a non-profit organization such as a hospital, university lab, or research facility.
Industry/Pharmaceutical Members?are those who work in for-profit businesses such as providers of medical services and products, biotechnology companies, pharmaceutical companies, and companies who offer services and products to academic and research companies and institutions.
Retired Fellow:?Retaining access to the deep understanding of HBV and institutional knowledge possessed by retired HBV researchers is beneficial to the HBV research community and attendees at the International HBV Meeting. To encourage continued attendance at the HBV Meeting by retirees, registration fees will be waived for retired HBV researchers who spent the majority of their careers in academia.?This waiver does not include expenses for travel, housing or the end-of-meeting banquet when the banquet fee is not bundled into the registration fee. Support for those expenses is at the discretion of the annual meeting organizers, with the understanding that the retirees receiving expanded financial support should have a formal role in the meeting, such as giving a keynote presentation. Researchers who spent the majority of their careers in industry are not eligible for this waiver. The Hepatitis B Foundation will notify the chairperson of the Scientific Advisory Council (SAC) when attendees register under the fee waiver option. Questions regarding eligibility for the fee waiver will be resolved by the SAC, and the SAC chairperson is authorized to act on behalf of the SAC for minor matters.
◆ 參會對象：醫(yī)生、醫(yī)院科室主任/副主任、住院醫(yī)師、醫(yī)院管理者、醫(yī)護人員以及從事該領域研究的科學家、研究人員、醫(yī)藥企業(yè)代表等等。
|
